Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine

We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, Jaime A., Méndez, María Isabel, Berman, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103461/
https://www.ncbi.nlm.nih.gov/pubmed/33705346
http://dx.doi.org/10.4269/ajtmh.20-1510
_version_ 1783689313356087296
author Soto, Jaime A.
Méndez, María Isabel
Berman, Jonathan D.
author_facet Soto, Jaime A.
Méndez, María Isabel
Berman, Jonathan D.
author_sort Soto, Jaime A.
collection PubMed
description We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adverse drug reactions are very common. These reports exemplify that this infrequent presentation of COVID-19 is likely to be ascribed to a more common etiology such as a gastrointestinal drug reaction.
format Online
Article
Text
id pubmed-8103461
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The American Society of Tropical Medicine and Hygiene
record_format MEDLINE/PubMed
spelling pubmed-81034612021-05-10 Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine Soto, Jaime A. Méndez, María Isabel Berman, Jonathan D. Am J Trop Med Hyg Articles We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adverse drug reactions are very common. These reports exemplify that this infrequent presentation of COVID-19 is likely to be ascribed to a more common etiology such as a gastrointestinal drug reaction. The American Society of Tropical Medicine and Hygiene 2021-05 2021-03-11 /pmc/articles/PMC8103461/ /pubmed/33705346 http://dx.doi.org/10.4269/ajtmh.20-1510 Text en © The American Society of Tropical Medicine and Hygiene https://creativecommons.org/licenses/by-nc/4.0/Open Access statement. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.
spellingShingle Articles
Soto, Jaime A.
Méndez, María Isabel
Berman, Jonathan D.
Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title_full Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title_fullStr Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title_full_unstemmed Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title_short Case Report: COVID-19 Misdiagnosed as a Drug Reaction to Miltefosine
title_sort case report: covid-19 misdiagnosed as a drug reaction to miltefosine
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103461/
https://www.ncbi.nlm.nih.gov/pubmed/33705346
http://dx.doi.org/10.4269/ajtmh.20-1510
work_keys_str_mv AT sotojaimea casereportcovid19misdiagnosedasadrugreactiontomiltefosine
AT mendezmariaisabel casereportcovid19misdiagnosedasadrugreactiontomiltefosine
AT bermanjonathand casereportcovid19misdiagnosedasadrugreactiontomiltefosine

Ejemplares similares